Pharmaceutical Products
Description
Product name Letrozole
Other name Femara
CAS register number 112809-51-5
EINECS ---
Molecular formula C17H11N5
Molecular weight 285.3
Molecular structure
Assay 99%
Product features Letrozole is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women.
Letrozole is intended for use only by women who are no longer of childbearing age. Possible candidates must have already ceased to menstruate. It is often used in patients who have already undergone other cancer treatments, such as radiation, chemotherapy, and used other cancer drugs, like tamoxifen. This nonsteroidal aromatase inhibitor may help prevent any remaining cancer cells from spreading.
Customs clearance Don& acute;t have to worry about cystoms pass rate,our customs clearance is 100%
Product packing Discreet package .The packing suits you best would be choosen to cross customs safely. Or if you have your own ideal way, it could be also take into consideration .
After-sales service Warm after-sale service for you 24/7. Any of your question would be solved for the first as soon as possible.
Security shipping Security Shipping:Shipping by express (FedEx,UPS,DHL,EMS), by air.The most professional forwarder would be recommanded for you.
Delivery time We have stock, so we can delivery quickly at the very day when receive the payment.
Condition payment condition payment:Western union, money gram, T/T
Read More
Wuhan Yuancheng Gongchuang Technology Co.Ltd.
Steroid, Oxymetholone,Oxandrolone, Stanozolol, Methandienone,Drostanolone聽Enanthate聽
Address: No.496,Zhongshan Road, Wuhan, Hubei, China,
wuhan, hubei
China, 430000
Tel: 18872220684
Fax: 0756-68886686
